by Innovit Corporate Affairs | Sep 2, 2020 | Blog
Mistake by Florida on child COVID-19 rate raises the question: Can Florida’s numbers be trusted? “It’s unacceptable to publish information that changes so dramatically that it warrants explanation, and then to not provide any explanation,” said...
by Innovit Corporate Affairs | Jul 7, 2020 | Blog, UDI
The US Food and Drug Administration (FDA) has released new guidance regarding Unique Device Identification (UDI) compliance dates for Class I and unclassified medical devices. Effective immediately, the FDA has postponed GUDID (Global UDI Database) compliance for...
by Innovit Corporate Affairs | Apr 7, 2020 | Blog
On March 11, 2020, the World Health Organization designated “coronavirus disease 2019” (COVID-19) a global pandemic. As the number of cases worldwide continues to grow exponentially, social distancing has become the norm to slow the rate of transmission. The goal of...
by Innovit Corporate Affairs | Mar 30, 2020 | Blog
Medical Device manufacturers are grappling with disruptions to their businesses as a result of the coronavirus pandemic. Many are experiencing adverse impact to their supply chain and operations, financial expectations and emergency response plans. The need for...
by Innovit Corporate Affairs | Mar 30, 2020 | News
Together, we face an unprecedented global coronavirus pandemic (COVID-19) and its impact on our families, businesses and communities. As we continue to monitor the rapidly evolving situation around COVID-19, our first thought is for the health and safety of our...
